Tumor Infiltrating Lymphocytes (TILs) Open New Era in Cancer Treatment WELLESLEY, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Adoptive cell therapies (ACTs), and recently the infusion of autologous or redirected tumor-specific T-cells, have the potential to drastically...